Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
GABRB3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
Congenital Anomalies of the Gastrointestinal Tract Panel PreventionGenetics, part of Exact Sciences United States | 297 | 180 |
|
Genetic Services Laboratory University of Chicago United States | 47 | 125 |
|
Autism Spectrum Disorders (ASD) Panel PreventionGenetics, part of Exact Sciences United States | 224 | 170 |
|
Top 99 Genetic Causes of Developmental Delay Panel PreventionGenetics, part of Exact Sciences United States | 170 | 99 |
|
Invitae Neurotransmitter Disorders Panel Invitae United States | 52 | 44 |
|
Invitae United States | 466 | 297 |
|
Childhood Absence Epilepsy and Epileptic Encephalopathy via the GABRB3 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Early Infantile Epileptic Encephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 144 | 124 |
|
Early Infantile Epileptic Encephalopathy Panel Genetic Services Laboratory University of Chicago United States | 47 | 125 |
|
Fulgent Genetics United States | 354 | 209 |
|
GABA Metabolism Deficiency NGS Panel Fulgent Genetics United States | 24 | 30 |
|
Fulgent Genetics United States | 509 | 275 |
|
Neurotransmitter Metabolism Deficiency NGS Panel Fulgent Genetics United States | 85 | 101 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Infantile Spasms Athena Diagnostics United States | 18 | 16 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Athena Diagnostics United States | 80 | 84 |
|
Asper Biogene Asper Biogene LLC Estonia | 210 | 204 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.